SmithKline Beckman Corp.: The Philadelphia-based pharmaceutical and...
- Share via
SmithKline Beckman Corp.: The Philadelphia-based pharmaceutical and eye- and skin-care company reported first-quarter profit of $130.2 million, down 22% from a year ago. Sales totaled $1.24 billion, up 7%. The results reflected the fact pharmaceutical sales were 5% lower than the 1988 first quarter.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
